Abstract
The invention in this patent application relates to compounds having structures represented generally herein by formula 1. These compounds are modulators of alpha 4 beta 7 integrin and may provide useful treatment for several inflammatory conditions such as inflammatory bowel diseases, including ulcerative colitis and Crohn's disease.